drugset / Trial / NCT05852002

A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer

NCT05852002 ↗

NaSingle-groupOpen-labelTreatment

Summary

In this research, the patients with advanced lung cancer accompanied by pain and discomfort were treated by injecting freshly manufactured tissue permeable hyaluronan fragment HA35 into the tissue under abdominal adipose.

Timeline

Start
2023-04-11
Primary completion
2023-11-01
Completion
2023-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 35 kDa hyaluronan fragment Unknown 100 mg Subcutaneous

Indications